JP2023531511A5 - - Google Patents
Info
- Publication number
- JP2023531511A5 JP2023531511A5 JP2022579691A JP2022579691A JP2023531511A5 JP 2023531511 A5 JP2023531511 A5 JP 2023531511A5 JP 2022579691 A JP2022579691 A JP 2022579691A JP 2022579691 A JP2022579691 A JP 2022579691A JP 2023531511 A5 JP2023531511 A5 JP 2023531511A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- utr
- sequence number
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063042822P | 2020-06-23 | 2020-06-23 | |
| US63/042,822 | 2020-06-23 | ||
| US202163165094P | 2021-03-23 | 2021-03-23 | |
| US63/165,094 | 2021-03-23 | ||
| US202163165469P | 2021-03-24 | 2021-03-24 | |
| US63/165,469 | 2021-03-24 | ||
| PCT/US2021/038780 WO2021262909A2 (en) | 2020-06-23 | 2021-06-23 | Lnp compositions comprising mrna therapeutics with extended half-life |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023531511A JP2023531511A (ja) | 2023-07-24 |
| JP2023531511A5 true JP2023531511A5 (cg-RX-API-DMAC10.html) | 2024-07-01 |
| JP7888475B2 JP7888475B2 (ja) | 2026-07-13 |
Family
ID=77155849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022579691A Active JP7888475B2 (ja) | 2020-06-23 | 2021-06-23 | 半減期が延長されたmRNA治療薬を含むLNP組成物 |
Country Status (11)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023183909A2 (en) * | 2022-03-25 | 2023-09-28 | Modernatx, Inc. | Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemia |
| TW202345870A (zh) * | 2022-03-25 | 2023-12-01 | 美商現代公司 | 具有延長半衰期之信使核糖核酸 |
| WO2023196399A1 (en) * | 2022-04-06 | 2023-10-12 | Modernatx, Inc. | Lipid nanoparticles and polynucleotides encoding argininosuccinate lyase for the treatment of argininosuccinic aciduria |
| WO2023215498A2 (en) * | 2022-05-05 | 2023-11-09 | Modernatx, Inc. | Compositions and methods for cd28 antagonism |
| KR20250047490A (ko) * | 2023-09-27 | 2025-04-04 | 한미약품 주식회사 | 변형된 폴리아데닐 서열 및 ox40l 단백질 코딩서열을 포함하는 핵산 분자 |
| KR20250047488A (ko) * | 2023-09-27 | 2025-04-04 | 한미약품 주식회사 | 변형된 폴리아데닐 서열을 포함하는 핵산 분자 |
| KR20250047489A (ko) * | 2023-09-27 | 2025-04-04 | 한미약품 주식회사 | 변형된 폴리아데닐 서열 및 p53 단백질 코딩서열을 포함하는 핵산 분자 |
| CN117603029B (zh) * | 2023-11-21 | 2025-12-19 | 江苏禾本生化有限公司 | 一种戊菌唑关键中间体的合成方法 |
| WO2025255199A1 (en) * | 2024-06-05 | 2025-12-11 | Modernatx, Inc. | Argininosuccinate synthase 1 and argininosuccinate lyase polypeptides and polynucleotides and uses thereof |
| WO2026038929A1 (ko) * | 2024-08-16 | 2026-02-19 | 서울대학교산학협력단 | Rna 안정성 또는 mrna 번역 증가용 신규 조절 엘리먼트 및 이의 용도 |
| WO2026085234A1 (en) * | 2024-10-18 | 2026-04-23 | Modernatx, Inc. | 3' untranslated region sequences for extending messenger ribonucleic acids half-life |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8613481D0 (en) | 1986-06-04 | 1986-07-09 | Diatech Ltd | Translation of mrna |
| US5723332A (en) | 1993-11-26 | 1998-03-03 | British Technology Group Limited | Translational enhancer DNA |
| US5824497A (en) | 1995-02-10 | 1998-10-20 | Mcmaster University | High efficiency translation of mRNA molecules |
| EP2428570B1 (en) | 2001-09-28 | 2018-05-23 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Microrna molecules |
| US20050222064A1 (en) | 2002-02-20 | 2005-10-06 | Sirna Therapeutics, Inc. | Polycationic compositions for cellular delivery of polynucleotides |
| WO2005013901A2 (en) | 2003-07-31 | 2005-02-17 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
| DE102005046490A1 (de) | 2005-09-28 | 2007-03-29 | Johannes-Gutenberg-Universität Mainz | Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen |
| DK2205618T3 (en) | 2007-09-26 | 2017-02-20 | Intrexon Corp | SYNTHETIC 5 'NON-TRANSLATED REGIONS, EXPRESSION VECTORS AND PROCEDURES FOR INCREASING TRANSGENIC EXPRESSION |
| JP5539962B2 (ja) | 2008-04-25 | 2014-07-02 | ノースウェスタン、ユニバーシティ | コレステロールを隔離するのに適したナノ構造体 |
| PL215513B1 (pl) | 2008-06-06 | 2013-12-31 | Univ Warszawski | Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka |
| KR20220038506A (ko) | 2009-06-10 | 2022-03-28 | 알닐람 파마슈티칼스 인코포레이티드 | 향상된 지질 조성물 |
| US9999673B2 (en) | 2011-01-11 | 2018-06-19 | Alnylam Pharmaceuticals, Inc. | PEGylated lipids and their use for drug delivery |
| EP3434774A1 (en) | 2013-01-17 | 2019-01-30 | ModernaTX, Inc. | Signal-sensor polynucleotides for the alteration of cellular phenotypes |
| WO2014164253A1 (en) | 2013-03-09 | 2014-10-09 | Moderna Therapeutics, Inc. | Heterologous untranslated regions for mrna |
| WO2015130584A2 (en) | 2014-02-25 | 2015-09-03 | Merck Sharp & Dohme Corp. | Lipid nanoparticle vaccine adjuvants and antigen delivery systems |
| US11866754B2 (en) | 2015-10-16 | 2024-01-09 | Modernatx, Inc. | Trinucleotide mRNA cap analogs |
| RS63625B1 (sr) | 2016-05-18 | 2022-10-31 | Modernatx Inc | Kombinacije irnk koje kodiraju imunomodulirajuće polipeptide i njihova upotreba |
| JP2022500436A (ja) * | 2018-09-13 | 2022-01-04 | モダーナティエックス・インコーポレイテッドModernaTX, Inc. | 糖原病を処置するためのグルコース−6−ホスファターゼをコードするポリヌクレオチド |
| MA53615A (fr) * | 2018-09-14 | 2021-07-21 | Modernatx Inc | Polynucléotides codant pour le polypeptide a1, de la famille de l'uridine diphosphate glycosyltransférase 1, pour le traitement du syndrome de crigler-najjar |
| EP4087544A1 (en) * | 2020-01-10 | 2022-11-16 | ModernaTX, Inc. | Methods of making tolerogenic dendritic cells |
| EP4096720A2 (en) * | 2020-01-30 | 2022-12-07 | ModernaTX, Inc. | Mrnas encoding metabolic reprogramming polypeptides and uses thereof |
| CN118369111A (zh) * | 2021-12-08 | 2024-07-19 | 摩登纳特斯有限公司 | 单纯疱疹病毒mRNA疫苗 |
-
2021
- 2021-06-23 IL IL299196A patent/IL299196A/en unknown
- 2021-06-23 US US18/012,094 patent/US20230242908A1/en active Pending
- 2021-06-23 AU AU2021297248A patent/AU2021297248A1/en not_active Abandoned
- 2021-06-23 CA CA3187261A patent/CA3187261A1/en active Pending
- 2021-06-23 KR KR1020237000782A patent/KR20230042005A/ko not_active Withdrawn
- 2021-06-23 BR BR112022025991A patent/BR112022025991A2/pt not_active Application Discontinuation
- 2021-06-23 JP JP2022579691A patent/JP7888475B2/ja active Active
- 2021-06-23 CN CN202180051902.6A patent/CN116194151A/zh active Pending
- 2021-06-23 EP EP21748991.3A patent/EP4168556A2/en active Pending
- 2021-06-23 WO PCT/US2021/038780 patent/WO2021262909A2/en not_active Ceased
- 2021-06-23 MX MX2022016550A patent/MX2022016550A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE112021000012B4 (de) | Coronavirus-Vakzine | |
| US11241493B2 (en) | Coronavirus vaccine | |
| AU2019277361B2 (en) | Messenger RNA vaccines and uses thereof | |
| US6727355B2 (en) | Pharmaceutical composition for treatment of Duchenne muscular dystrophy | |
| JP2024514183A (ja) | エプスタイン-バーウイルスmRNAワクチン | |
| CN115175698A (zh) | 冠状病毒rna疫苗 | |
| DE202019006108U1 (de) | Neue RSV-RNA-Moleküle und Zusammensetzungen für die Impfung | |
| JP2023526059A5 (cg-RX-API-DMAC10.html) | ||
| CN116617382B (zh) | 新型冠状病毒疫苗及其制备方法和应用 | |
| WO2023137550A1 (en) | Compositions and methods for the prevention and/or treatment of covid-19 | |
| WO2024055272A1 (zh) | 能高效表达目的基因的mRNA载体系统、其构建及应用 | |
| CN116615233A (zh) | 用于使生物分子在受试者中表达的系统和方法 | |
| DE202023106198U1 (de) | Impfstoff auf Nukleinsäurebasis | |
| CN120813371A (zh) | 用于在衣原体病的治疗中使用的组合物 | |
| WO2023050003A1 (en) | Compositions and methods for the prevention and/or treatment of covid-19 | |
| JP2025510777A5 (cg-RX-API-DMAC10.html) | ||
| US20230084012A1 (en) | Vaccine for use against coronavirus and variants thereof | |
| KR20260042173A (ko) | 알파-1 안티트립신 결핍증을 위한 치료 | |
| KR20250099770A (ko) | 코로나바이러스에 대한 백신 | |
| WO2024235231A1 (en) | Compositions and methods for the prevention and/or treatment of covid-19 | |
| WO2024073848A1 (en) | Compositions and methods for the prevention and/or treatment of covid-19 | |
| WO2026030201A2 (en) | Vaccine antigens and use thereof | |
| HK40090393B (en) | Novel coronavirus vaccine, preparation method and use thereof | |
| WO2026055516A1 (en) | Method for prevention and treatment of viral disease | |
| HK40090393A (en) | Novel coronavirus vaccine, preparation method and use thereof |